In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2021-07-12
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$33.64-93,295232,550-29%-$3,138,273
D
2021-07-09
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$32.62-50,000232,550-18%-$1,631,037
D
2021-07-07
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$32.27-32,308232,550-12%-$1,042,660
D
2021-06-28
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$32.39-6,812232,550-3%-$220,608
2021-06-28
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$132.73-553,37610,000-98%-$73,448,879
D
2021-06-25
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$31.96-83,372232,550-26%-$2,664,216
2021-06-16
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$24.37-2,253102,440-2%-$54,912
2021-06-17
MYGNMyriad Genetics IncSpiegelman Daniel KDirS - Sale$30.52-3,13923,129-12%-$95,795
M
2021-06-11
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$87.04-201,7251,127,405-15%-$17,558,774
2021-06-04
LNTHLantheus Holdings, Inc.Montagut EtienneChief Business OfficerS - Sale$24.60-7,43587,719-8%-$182,901
2021-06-04
HSKAHeska CorpWisnewski NancyCOOS - Sale$197.87-5,00055,505-8%-$989,326
2021-05-28
VNRXVolitionrx LtdTerrell Jason Bradley MdChief Medical OfficerS - Sale$3.54-10,00024,949-29%-$35,400
2021-05-28
MYGNMyriad Genetics IncSpiegelman Daniel KDirS - Sale$28.99-7,14213,420-35%-$207,023
2021-05-28
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$558.44-2,0002,986-40%-$1,116,884
D
2021-05-28
IDXXIdexx Laboratories Inc /dePolewaczyk James FEVPS - Sale+OE$561.91-10,00019,915-33%-$5,619,057
D
2021-05-28
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$562.26-9,460654,701-1%-$5,318,989
2021-05-27
ACHVAchieve Life Sciences, Inc.Bencich JohnCEOP - Purchase$7.00+6,0006,141>999%+$42,000
2021-05-24
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$546.24-2,9004,966-37%-$1,584,100
DM
2021-05-24
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$549.57-10,000663,701-1%-$5,495,735
D
2021-05-24
HSKAHeska CorpLarson Sharon J.DirS - Sale+OE$205.00-3,0007,501-29%-$615,000
D
2021-05-21
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$539.57-2,5002,886-46%-$1,348,918
M
2021-05-20
IDXXIdexx Laboratories Inc /deTurner Kathy VSVPS - Sale$540.00-3,0007,866-28%-$1,620,000
D
2021-05-20
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$537.07-5,000663,701-1%-$2,685,324
D
2021-05-18
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$528.02-7,632663,701-1%-$4,029,809
2021-05-14
VNRXVolitionrx LtdNguyen KimDirP - Purchase$3.20+2,00048,056+4%+$6,400
M
2021-05-14
VNRXVolitionrx LtdInnes Guy ArchibaldDirP - Purchase$3.35+150,0001,940,701+8%+$502,500
D
2021-05-13
QDELQuidel Corp /de/Slacik Charles PDirS - Sale+OE$113.26-1,00012,199-8%-$113,258
2021-05-12
ABIOArca Biopharma, Inc.Conway Robert EChairman of the BoardP - Purchase$3.19+10,00050,000+25%+$31,947
2021-05-10
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale$541.02-512663,7010%-$277,000
2021-05-05
ABIOArca Biopharma, Inc.Conway Robert EChairman of the BoardP - Purchase$3.23+10,00040,000+33%+$32,345
D
2021-05-04
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$31.97-19,360265,922-7%-$618,949
D
2021-05-03
QDELQuidel Corp /de/Ferenczy William J.SVP, Cardio, Metabolic UnitS - Sale+OE$105.74-8035,324-13%-$84,909
D
2021-05-03
NEOGNeogen CorpMorrical Terri ASenior Director, Special ProjeS - Sale+OE$97.00-4,18437,575-10%-$405,860
2021-05-03
NEOGNeogen CorpLilly Jason WarrenVP, InternationalS - Sale$96.73-35010,003-3%-$33,856
2021-04-29
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$85.43-4,513765,101-1%-$385,546
M
2021-04-26
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$85.96-342,962769,614-31%-$29,482,338
D
2021-04-27
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$31.47-40,000265,922-13%-$1,258,800
D
2021-04-26
NEOGNeogen CorpMorrical Terri ASenior Director, Special ProjeS - Sale+OE$97.02-1,92137,575-5%-$186,381
M
2021-04-21
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$2.08+40,0003,550,550+1%+$83,273
2021-04-23
NAVBNavidea Biopharmaceuticals, Inc.Witter Malcolm GDirP - Purchase$1.60+10,00057,000+21%+$16,000
2021-04-19
MYGNMyriad Genetics IncLambert NicoleSee RemarksS - Sale$27.01-6,649129,119-5%-$179,586
2021-04-16
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$21.75-7,500109,472-6%-$163,125
D
2021-04-14
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$93.93-13,00113,470-49%-$1,221,153
2021-04-13
NEOGNeogen CorpLilly Jason WarrenVP, InternationalS - Sale$92.25-99310,353-9%-$91,604
2021-04-12
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$20.66-19,421703,762-3%-$401,277
2021-04-09
LNTHLantheus Holdings, Inc.McHugh JulieDirS - Sale$21.22-2,80023,057-11%-$59,416
2021-04-08
LNTHLantheus Holdings, Inc.Leno Sam RDirS - Sale$21.17-5,00040,784-11%-$105,840
2021-04-05
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$84.98-8001,112,5760%-$67,984
D
2021-04-05
NTLAIntellia Therapeutics, Inc.Dorsa CarolineDirS - Sale+OE$82.19-7,5005,410-58%-$616,405
D
2021-03-31
NEOGNeogen CorpMorrical Terri ASenior Director, Special ProjeS - Sale+OE$88.03-31,40137,575-46%-$2,764,230
D
2021-04-01
NTLAIntellia Therapeutics, Inc.Leonard John MPres, CEOS - Sale+OE$83.64-38,209751,783-5%-$3,195,661
D
2021-04-01
NTLAIntellia Therapeutics, Inc.Rivera Jose EEVP, GCS - Sale+OE$82.46-50,455424,598-11%-$4,160,559
D
2021-03-31
NEOGNeogen CorpAdent John EdwardPres, CEOS - Sale+OE$87.99-40,46420,080-67%-$3,560,395
D
2021-03-31
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$88.07-15,00013,470-53%-$1,321,058
D
2021-03-30
NEOGNeogen CorpAdent John EdwardPres, CEOS - Sale+OE$87.09-9,53620,080-32%-$830,486
D
2021-03-31
NEOGNeogen CorpBoehm William TDirS - Sale+OE$88.25-2,00010,479-16%-$176,500
D
2021-03-29
NEOGNeogen CorpMorrical Terri ASenior Director, Special ProjeS - Sale+OE$87.99-60037,575-2%-$52,795
D
2021-03-29
MYGNMyriad Genetics IncHart Jayne B.Chief People OfficerS - Sale+OE$30.00-58,00080,128-42%-$1,740,000
2021-03-29
NAVBNavidea Biopharmaceuticals, Inc.Witter Malcolm GDirP - Purchase$2.07+21,50047,000+84%+$44,505
D
2021-03-25
NEOGNeogen CorpPapesh BruceDirS - Sale+OE$85.42-7,00036,261-16%-$597,957
2021-03-19
OCXOncocyte CorpAndrews Ronald AsburyCEOP - Purchase$4.79+11,000113,698+11%+$52,702
D
2021-03-17
QDELQuidel Corp /de/Ferenczy William J.SVP, Cardio, Metabolic UnitS - Sale+OE$136.06-7,4005,106-59%-$1,006,837
2021-03-17
VIVOMeridian Bioscience IncKenny John P.CEOS - Sale$25.00-30,000208,659-13%-$750,000
2021-03-10
VIVOMeridian Bioscience IncKenny John P.CEOS - Sale$25.00-10,000238,659-4%-$250,000
2021-03-05
LNTHLantheus Holdings, Inc.Maeusli Heinz ChristophDirP - Purchase$18.60+1,00016,211+7%+$18,600
2021-03-05
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$18.26-27,157723,184-4%-$495,838
2021-03-04
LNTHLantheus Holdings, Inc.Blanchfield PaulChief Commercial OfficerS - Sale$18.40-4,06160,329-6%-$74,722
2021-03-04
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$18.40-1,887104,693-2%-$34,721
M
2021-03-04
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$18.97-6,769116,972-5%-$128,379
2021-03-04
LNTHLantheus Holdings, Inc.Marshall Robert J. Jr.CFO, TreasurerS - Sale$18.40-2,280136,509-2%-$41,952
2021-03-04
LNTHLantheus Holdings, Inc.Molnar IstvanChief Medical OfficerS - Sale$18.40-4,02758,950-6%-$74,097
2021-03-03
NAVBNavidea Biopharmaceuticals, Inc.Witter Malcolm GDirP - Purchase$2.31+15,00025,500+143%+$34,650
2021-03-01
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$19.08-1,473101,929-1%-$28,108
2021-03-01
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$19.08-1,18759,232-2%-$22,650
2021-03-01
LNTHLantheus Holdings, Inc.Marshall Robert J. Jr.CFO, TreasurerS - Sale$19.08-1,46579,265-2%-$27,955
2021-02-26
LNTHLantheus Holdings, Inc.Maeusli Heinz ChristophDirP - Purchase$18.02+1,00015,211+7%+$18,020
2021-02-26
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$60.29-501,9451,113,376-31%-$30,262,716
D
2021-02-23
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale+OE$513.41-3,04614,696-17%-$1,563,840
DM
2021-02-22
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale+OE$166.79-22,9028,119-74%-$3,819,747
D
2021-02-22
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$538.57-1,8982,875-40%-$1,022,207
2021-02-19
LNTHLantheus Holdings, Inc.Maeusli Heinz ChristophDirP - Purchase$19.39+1,00014,211+8%+$19,390
2021-02-22
QDELQuidel Corp /de/Bryant Douglas CPres, CEOP - Purchase$165.30+5,000495,807+1%+$826,500
D
2021-02-18
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$555.56-1,000662,7370%-$555,561
D
2021-02-17
IDXXIdexx Laboratories Inc /deMazelsky Jonathan JayPres, CEOS - Sale+OE$537.21-13,86854,222-20%-$7,449,969
D
2021-02-16
IDXXIdexx Laboratories Inc /deClaflin Bruce L.DirS - Sale+OE$536.91-7,3310-100%-$3,936,089
D
2021-02-16
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$539.58-1,30742,764-3%-$705,231
D
2021-02-16
IDXXIdexx Laboratories Inc /deLane MichaelEVPS - Sale+OE$545.00-8504,216-17%-$463,250
D
2021-02-16
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$29.71-80,000246,575-24%-$2,377,048
2021-02-12
LNTHLantheus Holdings, Inc.Maeusli Heinz ChristophDirP - Purchase$20.03+1,00013,211+8%+$20,030
D
2021-02-16
VIVOMeridian Bioscience IncKenny John P.CEOS - Sale+OE$30.35-2,359248,659-1%-$71,604
D
2021-02-12
IDXXIdexx Laboratories Inc /deVandebroek Sophie V.DirS - Sale+OE$538.20-3,0469,321-25%-$1,639,357
DM
2021-02-11
VIVOMeridian Bioscience IncKenny John P.CEOS - Sale+OE$30.13-27,501248,936-10%-$828,686
D
2021-02-08
VIVOMeridian Bioscience IncKenny John P.CEOS - Sale+OE$29.86-68,288252,176-21%-$2,039,114
D
2021-02-09
NTLAIntellia Therapeutics, Inc.Rivera Jose EEVP, GCS - Sale+OE$75.00-11,489380,130-3%-$861,675
DM
2021-02-05
NTLAIntellia Therapeutics, Inc.Leonard John MPres, CEOS - Sale+OE$71.70-50,985718,951-7%-$3,655,410
D
2021-02-05
LHDXLucira Health, Inc.Epiq Capital Group, LLC10%P - Purchase$17.00+3,461,7643,461,764New+$58,849,988
2021-02-05
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$4.50+600,00033,556,113+2%+$2,700,000
2021-02-05
LNTHLantheus Holdings, Inc.Maeusli Heinz ChristophDirP - Purchase$17.94+1,00012,211+9%+$17,940
D
2021-02-08
VIVOMeridian Bioscience IncRice John McCune Jr.DirS - Sale+OE$28.16-16,48024,437-40%-$464,008
D
2021-02-08
VIVOMeridian Bioscience IncBaldasare Bryan TEVP, CFOS - Sale+OE$30.00-6,25456,128-10%-$187,620

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top